Cost-constrained optimal sampling for system identification in pharmacokinetics applications with population priors and nuisance parameters

Journal of Pharmaceutical Sciences
Carlos Oscars S SorzanoAntonio Aguilar Ros

Abstract

Pharmacokinetics (PK) applications can be seen as a special case of nonlinear, causal systems with memory. There are cases in which prior knowledge exists about the distribution of the system parameters in a population. However, for a specific patient in a clinical setting, we need to determine her system parameters so that the therapy can be personalized. This system identification is performed many times by measuring drug concentrations in plasma. The objective of this work is to provide an irregular sampling strategy that minimizes the uncertainty about the system parameters with a fixed amount of samples (cost constrained). We use Monte Carlo simulations to estimate the average Fisher's information matrix associated to the PK problem, and then estimate the sampling points that minimize the maximum uncertainty associated to system parameters (a minimax criterion). The minimization is performed employing a genetic algorithm. We show that such a sampling scheme can be designed in a way that is adapted to a particular patient and that it can accommodate any dosing regimen as well as it allows flexible therapeutic strategies.

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Apr 1, 1986·Diagnostic Cytopathology·K L Myrent
Aug 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio, D Katz
Oct 1, 1983·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio, K Khakmahd
Dec 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·D Z D'Argenio
Jun 1, 1994·International Journal of Bio-medical Computing·B LacarelleA Durand
Dec 18, 1998·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C A JonesL Y Agodoa
Nov 5, 1999·Annals of Biomedical Engineering·K Thomaseth, C Cobelli
Jun 29, 2002·Computer Methods and Programs in Biomedicine·Stephen B DuffullFrance Mentré
Nov 27, 2002·Cancer Chemotherapy and Pharmacology·Nadja E SchoemakerJos H Beijnen
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Vincent H TamG L Drusano
Mar 3, 2004·Computer Methods and Programs in Biomedicine·Marco ForacchiaAlfredo Ruggeri
Sep 6, 2005·Computer Methods and Programs in Biomedicine·Kayode OgungbenroLeon Aarons
Oct 6, 2005·Journal of Pharmacokinetics and Pharmacodynamics·Michael G DoddsPaolo Vicini
Dec 16, 2005·The AAPS Journal·Amit Roy, Ene I Ette
Nov 7, 2009·Computer Methods and Programs in Biomedicine·Caroline BazzoliFrance Mentré
May 25, 2010·Journal of Biopharmaceutical Statistics·Lee-Kien Foo, Stephen Duffull
May 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Michał KomorowskiMichael P H Stumpf
Nov 9, 2011·Antimicrobial Agents and Chemotherapy·William W Hope
May 30, 2012·Computer Methods and Programs in Biomedicine·Joakim NybergAndrew C Hooker

❮ Previous
Next ❯

Citations

Mar 23, 2021·Pharmaceutical Research·C O S SorzanoA Aguilar-Ros
Jun 24, 2021·Pharmaceutical Research·C O S SorzanoM A Pérez de la Cruz-Moreno

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.